The comparative study has been designed to estimate serum magnesium (Mg) and potassium (K) in patients with acute myocardial infarction (AMI) and chronic ischemic heart disease (CIHD). A total 61 subjects were selected and were divided as group-I (30 subjects of AMI) and group-II (31 subjects of CIHD). Laboratory investigations were done for estimation of serum glucose and serum creatinine to exclude the diabetesmellitus and renal disease. Serum Mg was estimated by atomic absorption spectrophotometer and serum K by ion selective electrode. This study showed that Mg and K level in serum is significantly lower in patients with AMI than that of CIHD subjects. Findings of the study suggested that significantly reduced serum level of Mg and K persists in AMI than those of CIHD, which may be the cause of further cardiac complications. So it may be recommended for estimation and supplementation of Mg and K in both the cases of AMI and CIHD patients for better management.
Introduction
Ischemic Heart Disease (IHD) is the generic designation for a group of closely related syndromes resulting from ischemia -an imbalance between the supply and demand of the heart for oxygenated blood. Ischemia comprises not only insufficiency of O 2 (hypoxia, anoxia), but also reduced availability of nutrient substrates and inadequate removal of metabolites. Because coronary artery narrowing or obstruction owing to atherosclerosis underlies myocardial ischemia in the vast majority of cases, IHD is often termed coronary artery disease (CAD) or coronary heart disease (CHD) 1 .
CHD is the commonest cause of heart disease and the most important single cause of death in the affluent countries of the World. Myocardial infarction (MI) is the term applied to myocardial necrosis secondary to an acute interruption of the coronary blood supply 2 . On the other hand Angina pectoris and old MI are considered as chronic ischemic heart disease (CIHD).
Magnesium (Mg) is the second most common intracellular electrolyte after potassium (K), and the fourth most abundant cation in the body. 
Subjects and Methods
The study was carried out in the biochemistry (Table-3 ). Means compared using Student's unpaired 't'
test.
The incidence of hypomagnesemia in AMI patients was 86.66% and in CIHD it was 58.06%. The incidence of hypokalemia in AMI patients was 60% and in CIHD it was 22.58%.
76.92% hypomagnesemia in hypokalemic subjects was reported in this study. Hypokalemia in this study were 60% patients with AMI and 22.58% in chronic IHD patients.
Discussion
In AMI patients it is much higher than 10% to 17% incidence reported by Dyckner (1980) 21 
Conclusion
Thus it is suggested from the above discussion that estimation and supplementation of both Mg and K is essential in case of IHD and AMI patients. But from the present study with a small sample size it is too early to confirm Mg and K as protective as well as curative agent for IHD.
So, further study involving a larger sample size in different states of IHD is needed.
